MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Therma Bright Inc (OP:TBRIF)

0.0402 UNCHANGED
Last Price Updated: 12:35 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0402
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0402
Today's Range 0.0402 - 0.0402
52wk Range 0.0255 - 0.0889
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
Toronto, Ontario--(Newsfile Corp. - June 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the... 
Via Newsfile
Topics Economy
News headline image
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the... 
Via Newsfile
Topics Economy

Performance

YTD
+5.5%
+5.5%
1 Month
+10.7%
+10.7%
3 Month
+0.5%
+0.5%
6 Month
-9.5%
-9.5%
1 Year
-3.1%
-3.1%

More News

Read More
News headline image
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
Via Newsfile
News headline image
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
Via Newsfile
News headline image
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Via Newsfile
News headline image
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Via Newsfile
News headline image
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
Via Newsfile
News headline image
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
Via Newsfile
News headline image
Therma Bright Announces Share Consolidation
Via Newsfile
News headline image
Therma Bright Inc. Announces Share Consolidation
Via Newsfile
News headline image
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
Via Newsfile
Topics Intellectual Property
News headline image
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
Via Newsfile
News headline image
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
Via Newsfile
Topics Economy Intellectual Property World Trade
News headline image
Image Protect Announces New Consumer Products Division and Secures Exclusive Marketing and Distribution Rights for Major Health-Related Products in Multi-Billion Dollar Sectors
Via NewMediaWire
Image Protect Announces New Consumer Products Division and Secures Exclusive Marketing and Distribution Rights for Major Health-Related Products in Multi-Billion Dollar Sectors
Via TheNewswire.com
News headline image
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
Via Newsfile
News headline image
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
Via Newsfile
News headline image
Therma Bright Reaffirms Its Position As A Key Player In The $4.2 Billion Compression Market With New Venowave Orders
Via AB Newswire
News headline image
Therma Bright Reaffirms Its Position As A Key Player In The $4.2 Billion Compression Market With New Venowave Orders
Via News Direct
News headline image
Therma Bright Inc. (OTC: TBRIF) Expands in $6.72 Billion Compression Market
Via AB Newswire
News headline image
Therma Bright Inc. (OTC: TBRIF) Expands in $6.72 Billion Compression Market
Via News Direct
News headline image
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
Via Newsfile
News headline image
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
Via Newsfile
News headline image
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Via Newsfile
News headline image
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
Via Newsfile

Frequently Asked Questions

Is Therma Bright Inc publicly traded?
Yes, Therma Bright Inc is publicly traded.
What exchange does Therma Bright Inc trade on?
Therma Bright Inc trades on the OTC Traded
What is the ticker symbol for Therma Bright Inc?
The ticker symbol for Therma Bright Inc is TBRIF on the OTC Traded
What is the current price of Therma Bright Inc?
The current price of Therma Bright Inc is 0.0402
When was Therma Bright Inc last traded?
The last trade of Therma Bright Inc was at 08/21/26 12:35 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story